查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608148

子宮內避孕器市場：按類型、年齡層、最終用戶分類 - 全球預測 2025-2030

Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年子宮內避孕器市場價值為31.3億美元，預計到2024年將達到32.4億美元，複合年成長率為4.59%，到2030年將達到42.9億美元。

子宮內避孕器器(IUD) 是長期避孕解決方案的重要組成部分。子宮內避孕器是一種小型 T 型避孕器，可插入子宮以防止懷孕，提供安全且可逆的選擇。這種需求源自於對計劃生育和生殖健康管理的日益重視。子宮內避孕器不僅用於避孕，也常用於治療月經疼痛等月經失調。主要最終用戶是已開發國家和開發中國家尋求有效避孕解決方案的婦女。市場成長受到多種因素的推動，例如性健康意識的提高、政府控制人口的努力以及醫療基礎設施的改善以促進性健康。在傳統上避孕器具使用率較低的農村地區，以及可以獲得諮詢和子宮內避孕器資訊的數位推廣保健平台上，存在著大量的機會。諸如具有延長保存期限的子宮內避孕器和荷爾蒙平衡等其他健康益處的技術進步也提供了一條充滿希望​​的前進道路。然而，存在一些限制可能會阻止某些人群，例如對副作用的誤解、某些地區的文化障礙以及植入的初始成本。市場挑戰包括潛在的併發症，例如插入後感染疾病以及醫療系統不太健全的低度開發地區的准入有限。創新研發領域包括開發經濟高效、生物分解性的子宮內避孕器和智慧設備，使醫療保健專業人員能夠遠端監測患者健康狀況。我們業務成長的驅動力是加強與醫療機構的夥伴關係以及促進教育和意識計劃。子宮內避孕器市場在高度創新和文化猶豫之間搖擺不定，巨大的機會在於解開子宮內避孕器被誤解的方面，並將其整合到更廣泛的醫療保健計劃中。對個人化醫療和生物技術進步的熱切關注有可能重新定義產品供應、滿足多樣化的消費者需求並推動市場的顯著擴張。

主要市場統計
基準年[2023] 31.3億美元
預計年份 [2024] 32.4億美元
預測年份 [2030] 42.9億美元
複合年成長率（%） 4.59%

市場動態：快速發展的子宮內避孕器市場的關鍵市場洞察

避孕器內避孕器市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 避免意外懷孕的做法越來越受歡迎
    • 政府和非政府組織努力普及子宮內避孕器
  • 市場限制因素
    • 使用子宮內避孕器時擔心帶子流失和感染風險
  • 市場機會
    • 專注於設計下一代 IUD（子宮內避孕器）
    • 智慧型子宮內避孕器的出現
  • 市場挑戰
    • 居民的認知與傳播有限

波特五力：駕馭子宮內避孕器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解子宮內避孕器市場的外在影響

外部宏觀環境因素對子宮內避孕器市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解子宮內避孕器市場的競爭狀況

對避孕器內避孕器市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣避孕器市場供應商的績效評估

FPNV定位矩陣是評估子宮內避孕器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪子宮內避孕器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對子宮內避孕器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加收養以避免意外懷孕
      • 政府和非政府組織努力推廣子宮內避孕器
    • 抑制因素
      • 使用子宮內避孕器時擔心線脫落和感染風險
    • 機會
      • 專注於設計下一代 IUD（子宮內避孕器）
      • 推出智慧型子宮內避孕器
    • 任務
      • 大眾的認知和採納有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章子宮內避孕器市場：依類型

  • 荷爾蒙：釋放黃體素的子宮內避孕器
  • 非荷爾蒙：含銅子宮內避孕器

第7章子宮內避孕器市場：依年齡層別

  • 15-24歲
  • 25-34歲
  • 35-44歲
  • 44歲以上

第8章子宮內避孕器市場：依最終用戶分類

  • 診所
  • 社區健康服務中心
  • 醫院

第9章 北美及南美子宮內避孕器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太宮內避孕器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲子宮內避孕器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Actavis Generics by Teva Pharmaceutical Industries Ltd.
  • Agile Therapeutics, Inc.
  • Allergan Plc by Abbvie Inc
  • Ava AG
  • Bayer AG
  • Cardinal Health, Inc.
  • Contrel Europe NV
  • CooperSurgical Inc.
  • Egemen International
  • ERENLER MEDIKAL SAN. TIC. LTD. STI.
  • Eurogine SL
  • Fuji Latex Co., Ltd.
  • HLL Lifecare Limited
  • HRA Pharma, SAS
  • Melbea AG
  • Merck & Co., Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Mona Lisa NV
  • Mylan NV by Viatris Inc.
  • Novartis AG
  • Ocon Medical Ltd
  • Pregna International Limited
  • Prosan International BV
  • Searchlight Pharma Inc.
  • SMB Corporation of India
Product Code: MRR-8E22B61932AA

The Intrauterine Devices Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.24 billion in 2024, and is projected to grow at a CAGR of 4.59%, to USD 4.29 billion by 2030.

Intrauterine devices (IUDs) represent a crucial segment of long-term contraceptive solutions. They are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy, offering a safe and reversible option. Their necessity stems from the growing emphasis on family planning and control over reproductive health. Applications extend beyond contraception, with IUDs often prescribed to manage menstruation disorders like menorrhagia. The primary end-users encompass women seeking effective birth control solutions across developed and developing regions. Market growth is driven by several factors including increased awareness about sexual health, government initiatives for population control, and improved healthcare infrastructure facilitating access. Opportunities abound in rural outreach programs where contraceptive use is traditionally lower and digital healthcare platforms that can provide consultations or make IUD information accessible. Technological advancements, such as IUDs with extended durations and additional health benefits like hormonal balance, also present promising avenues. However, limitations include misconceptions about side effects, cultural barriers in certain regions, and the initial cost of insertion which might deter certain demographics. Market challenges stem from potential complications like infections post-insertion and limited access in underdeveloped areas where healthcare systems are less robust. Innovative areas for research include developing cost-effective, biodegradable IUDs and smart devices that allow healthcare providers to monitor patient health remotely. Business growth can be driven by enhancing partnerships with healthcare agencies to promote education and awareness programs. The IUD market oscillates between high innovation and cultural hesitancy, with a significant opportunity lying in demystifying misunderstood aspects of IUDs and integrating them into broader healthcare plans. A keen focus on personalized medicine and biotech advancements could redefine the product offerings, meeting diverse consumer needs and fostering significant market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 4.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intrauterine Devices Market

The Intrauterine Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption to avoid unintended pregnancies
    • Government and NGO initiatives to promote IUD
  • Market Restraints
    • Concerns related to lost strings and risk of infection due to IUD usage
  • Market Opportunities
    • Focus on the design of next-generation IUD (intrauterine device)
    • Emergence of smart intrauterine contraceptive device
  • Market Challenges
    • Limited awareness and adoption among population

Porter's Five Forces: A Strategic Tool for Navigating the Intrauterine Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intrauterine Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intrauterine Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intrauterine Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intrauterine Devices Market

A detailed market share analysis in the Intrauterine Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intrauterine Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intrauterine Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intrauterine Devices Market

A strategic analysis of the Intrauterine Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDIKAL SAN. TIC. LTD. STI., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.

Market Segmentation & Coverage

This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Hormonal: Progestogen-releasing IUD and Nonhormonal: Copper-containing IUD.
  • Based on Age Group, market is studied across 15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years.
  • Based on End User, market is studied across Clinics, Community Health Care Centres, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption to avoid unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote IUD
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
      • 5.1.3.2. Emergence of smart intrauterine contraceptive device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and adoption among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intrauterine Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Hormonal: Progestogen-releasing IUD
  • 6.3. Nonhormonal: Copper-containing IUD

7. Intrauterine Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24 Years
  • 7.3. 25-34 Years
  • 7.4. 35-44 Years
  • 7.5. Above 44 Years

8. Intrauterine Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Health Care Centres
  • 8.4. Hospitals

9. Americas Intrauterine Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intrauterine Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intrauterine Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
  • 2. Agile Therapeutics, Inc.
  • 3. Allergan Plc by Abbvie Inc
  • 4. Ava AG
  • 5. Bayer AG
  • 6. Cardinal Health, Inc.
  • 7. Contrel Europe NV
  • 8. CooperSurgical Inc.
  • 9. Egemen International
  • 10. ERENLER MEDIKAL SAN. TIC. LTD. STI.
  • 11. Eurogine S.L.
  • 12. Fuji Latex Co., Ltd.
  • 13. HLL Lifecare Limited
  • 14. HRA Pharma, SAS
  • 15. Melbea AG
  • 16. Merck & Co., Inc.
  • 17. Meril Life Sciences Pvt. Ltd.
  • 18. Mona Lisa N.V.
  • 19. Mylan NV by Viatris Inc.
  • 20. Novartis AG
  • 21. Ocon Medical Ltd
  • 22. Pregna International Limited
  • 23. Prosan International BV
  • 24. Searchlight Pharma Inc.
  • 25. SMB Corporation of India

LIST OF FIGURES

  • FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 35-44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ABOVE 44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COMMUNITY HEALTH CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023